.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Howard L. Kaufman, MD

EP. 1: Society for Immunotherapy in Cancer

June 17th 2015

EP. 2: ImmunoScore: Predictive and Prognostic?

June 17th 2015

EP. 3: Advances in Immuno-Oncology

June 17th 2015

EP. 4: Emerging Agents and Approaches in Immunotherapy

June 17th 2015

EP. 5: Patient Selection for Immunotherapies

June 17th 2015

EP. 6: Identifying and Managing Toxicities of Immunotherapy

June 17th 2015

EP. 7: Biomarkers and Immunotherapy

June 17th 2015

EP. 8: Phase I Immunotherapy Trials

June 17th 2015

EP. 9: Clinical Trial Design for Immunotherapy

June 17th 2015

EP. 10: History and Evolution of Immuno-oncology

June 17th 2015